Detalles de la búsqueda
1.
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
Lancet Oncol
; 21(10): 1331-1340, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002437
2.
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
Lancet Oncol
; 18(9): 1192-1201, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28760403
3.
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
Lancet Oncol
; 17(6): 727-737, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27155740
4.
Tolerability and outcomes of curative radiotherapy in patients aged 85 or more years.
Med J Aust
; 202(3): 153-5, 2015 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25669479
5.
Effective and well tolerated: where do these drugs fit now?
Lancet Oncol
; 20(4): 469-470, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30770292
6.
The 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD)--where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial.
BJU Int
; 114 Suppl 1: 9-12, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25047091
7.
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
BJU Int
; 113 Suppl 2: 7-12, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24894850
8.
Cognitive Existential Couple Therapy for newly diagnosed prostate cancer patients and their partners: a descriptive pilot study.
Psychooncology
; 22(2): 465-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21990204
9.
Timing of androgen-deprivation therapy in prostate cancer - Author's reply.
Lancet Oncol
; 18(11): e635, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29208389
10.
Timing of androgen-deprivation therapy for prostate cancer: still a long way to go - Authors' reply.
Lancet Oncol
; 17(8): e313-e314, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27511148
11.
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy.
JNCI Cancer Spectr
; 6(3)2022 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35616109
12.
Extracting tumour prognostic factors from a diverse electronic record dataset in genito-urinary oncology.
Int J Med Inform
; 121: 53-57, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30545489
13.
Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performance.
Int J Radiat Oncol Biol Phys
; 70(4): 1169-75, 2008 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17967518
14.
Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer.
Int J Radiat Oncol Biol Phys
; 68(1): 24-33, 2007 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17448868
15.
An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk.
Int J Radiat Oncol Biol Phys
; 65(2): 351-7, 2006 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16530339
16.
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Radiother Oncol
; 81(1): 9-17, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17011058
17.
A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?
Brachytherapy
; 5(4): 256-61, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17118320
18.
Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques.
J Med Imaging Radiat Oncol
; 60(1): 129-37, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26439588
19.
Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
Brachytherapy
; 4(2): 146-53, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15893269
20.
Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework.
J Med Imaging Radiat Oncol
; 59(3): 363-70, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25345713